HUMANIGEN, INC Insider Trading for November 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HUMANIGEN, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in HUMANIGEN, INC for November 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 24 2015 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | Chief Executive Off ... | Buy | P | 38.15 | 5,000 | 190,750 | 2,075,200 | 2.1 M to 2.1 M (+0.24 %) |
| Nov 23 2015 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | Chief Executive Off ... | Buy | P | 18.88 | 5,000 | 94,400 | 2,070,200 | 2.1 M to 2.1 M (+0.24 %) |
| Nov 19 2015 | KBIO | KALOBIOS PHARMACEU ... | Anthion Partners II LLC | 10% Owner | Buy | P | 2.13 | 150,000 | 319,500 | 574,800 | 424.8 K to 574.8 K (+35.31 %) |
| Nov 19 2015 | KBIO | KALOBIOS PHARMACEU ... | Anthion Partners II LLC | 10% Owner | Buy | P | 2.13 | 150,000 | 319,500 | 574,800 | 424.8 K to 574.8 K (+35.31 %) |
| Nov 19 2015 | KBIO | KALOBIOS PHARMACEU ... | BIESTEK MAREK | Buy | P | 2.04 | 40,000 | 81,600 | 240,000 | 200 K to 240 K (+20.00 %) | |
| Nov 19 2015 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | 10% Owner | Buy | P | 2.02 | 440,000 | 888,800 | 2,065,200 | 1.6 M to 2.1 M (+27.07 %) |
| Nov 19 2015 | KBIO | KALOBIOS PHARMACEU ... | BIESTEK MAREK | Buy | P | 1.83 | 135,000 | 247,050 | 200,000 | 65 K to 200 K (+207.69 %) | |
| Nov 19 2015 | KBIO | KALOBIOS PHARMACEU ... | BIESTEK MAREK | Buy | P | 1.36 | 65,000 | 88,400 | 65,000 | 0 to 65 K | |
| Nov 18 2015 | KBIO | KALOBIOS PHARMACEU ... | Anthion Partners II LLC | 10% Owner | Buy | P | 1.69 | 113,800 | 192,322 | 424,800 | 311 K to 424.8 K (+36.59 %) |
| Nov 18 2015 | KBIO | KALOBIOS PHARMACEU ... | Anthion Partners II LLC | 10% Owner | Buy | P | 1.69 | 113,800 | 192,322 | 424,800 | 311 K to 424.8 K (+36.59 %) |
| Nov 18 2015 | KBIO | KALOBIOS PHARMACEU ... | Anthion Partners II LLC | 10% Owner | Buy | P | 1.76 | 17,100 | 30,096 | 311,000 | 293.9 K to 311 K (+5.82 %) |
| Nov 18 2015 | KBIO | KALOBIOS PHARMACEU ... | Anthion Partners II LLC | 10% Owner | Buy | P | 1.76 | 17,100 | 30,096 | 311,000 | 293.9 K to 311 K (+5.82 %) |
| Nov 18 2015 | KBIO | KALOBIOS PHARMACEU ... | Anthion Partners II LLC | 10% Owner | Buy | P | 1.26 | 225,963 | 284,713 | 293,900 | 67.9 K to 293.9 K (+332.61 %) |
| Nov 18 2015 | KBIO | KALOBIOS PHARMACEU ... | Anthion Partners II LLC | 10% Owner | Buy | P | 1.26 | 225,963 | 284,713 | 293,900 | 67.9 K to 293.9 K (+332.61 %) |
| Nov 18 2015 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | 10% Owner | Buy | P | 2.43 | 7,000 | 17,010 | 1,625,200 | 1.6 M to 1.6 M (+0.43 %) |
| Nov 18 2015 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | 10% Owner | Buy | P | 1.93 | 606,677 | 1,170,887 | 1,618,200 | 1 M to 1.6 M (+59.98 %) |
| Nov 18 2015 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | 10% Owner | Buy | P | 1.43 | 97,269 | 139,095 | 1,011,523 | 914.3 K to 1 M (+10.64 %) |
| Nov 18 2015 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | 10% Owner | Buy | P | 0.61 | 500,169 | 305,103 | 914,254 | 414.1 K to 914.3 K (+120.79 %) |
| Nov 10 2015 | KBIO | KALOBIOS PHARMACEU ... | CROSS HERB | Chief Financial Off ... | Option Exercise | A | 0.95 | 1,875 | 1,781 | 1,875 |